Reporter Feb 17 2023
Diabetes drug may improve asthma
Feb. 21, 2023—New biomarker finding strengthens the case for using GLP-1R agonists to treat patients with Type 2 diabetes who also suffer from asthma.
Probing hellbender health
Feb. 20, 2023—Understanding how hellbenders — large, fully aquatic salamanders — fight fungal pathogens and disease is important for protecting these unique stream predators; Vanderbilt researchers add new insights.
Breast cancer genetics: new insights
Feb. 16, 2023—Largest genetic study of breast cancer to date identifies 222 genetic risk loci, 137 genes and multiple signaling pathways associated with risk, providing important new insights.
Targeted therapy for neuroendocrine tumors
Feb. 16, 2023—Cancer therapies that target VEGF receptor appear safe and effective for patients with pancreatic and non-pancreatic neuroendocrine tumors, meta-analysis of phase 2/3 clinical trials demonstrates.
Research network yields significant findings related to obesity
Feb. 16, 2023— by Jill Clendening In 2017, Vanderbilt University Medical Center was selected to be one of four U.S. medical centers in a Strategically Focused Research Network (SFRN) on Obesity funded by a four-year, $15 million award from the American Heart Association to study obesity and train future obesity-focused investigators. Now, the findings of the research...
Wilkins appointed to National Academies of Sciences, Engineering and Medicine committee for Unequal Treatment Revisited
Feb. 16, 2023—Vanderbilt's Consuelo Wilkins, MD, MSCI, has been appointed to the National Academies of Sciences, Engineering and Medicine (NASEM) committee for Unequal Treatment Revisited.
Tennessee Advanced Communications Network expands to include state hospital systems
Feb. 16, 2023—Vanderbilt University Medical Center to be an early adopter as a hospital system integrating the Tennessee Advanced Communications Network into its existing network of emergency providers for redundancy communications in the event of a disaster.
Patient undergoes novel therapy to treat pancreatic cancer
Feb. 16, 2023—Maudean Armour of Clarksville, Tennessee, is the first patient in Tennessee to undergo intraoperative radiotherapy for pancreatic cancer — a new technology that targets any remaining cancer cells with electrons during surgery.
Tindle authors NCI guidance on treatment of cancer patient who smoke
Feb. 16, 2023—Vanderbilt's Hilary Tindle, MD, MPH, was one of the key contributors to the new Tobacco Control Monograph from the National Cancer Institute.
Penicillin allergy test recommended for pregnant women
Feb. 16, 2023—Vanderbilt experts say getting rid of unnecessary penicillin allergy labels allows women to receive better treatments for common infections during pregnancy and delivery.
REDCap day highlights tool’s new features, global impact
Feb. 16, 2023—REDCap Day (Research Electronic Data Capture) is an annual event featuring presentations and workshops for the Vanderbilt and Meharry Medical College research community.
Sir Paul Nurse Discovery Lecture
Feb. 16, 2023—Among those attending last week’s Discovery Lecture by Nobel laureate Sir Paul Nurse, PhD, were, Jackie Corbin, PhD, Kathy Gould, PhD, Sharron Francis, PhD, Nancy Carrasco, MD, and Roger Colbran, PhD.
